Double Blind Randomized Controlled Trial to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine.
Phase of Trial: Phase I
Latest Information Update: 23 Oct 2013
At a glance
- Drugs Influenza virus vaccine live (Primary) ; Lactobacillus rhamnosus (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 09 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 Mar 2012 New trial record